CA19-9 serum levels predict micrometastases in patients with gastric cancer

1 Kwee RM, Kwee TC. Imaging in assessing lymph node status in gastric cancer. Gastric Cancer 2009; 12: 6-22.KweeRMKweeTCImaging in assessing lymph node status in gastric cancerGastric Cancer20091262210.1007/s10120-008-0492-519390927Search in Google Scholar

2 Arai K, Iwasaki Y, Takahashi T. Clinicopathological analysis of early gastric cancer with solitary lymph node metastasis. Brit J Surg 2002; 89: 1435-7.AraiKIwasakiYTakahashiTClinicopathological analysis of early gastric cancer with solitary lymph node metastasisBrit J Surg2002891435710.1046/j.1365-2168.2002.02204.x12390388Search in Google Scholar

3 Yasuda K, Adachi Y, Shiraishi N, Inomata M, Takeuchi H, Kitano S. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol 2002; 9: 771-4.YasudaKAdachiYShiraishiNInomataMTakeuchiHKitanoSPrognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancerAnn Surg Oncol20029771410.1007/BF0257449912374660Search in Google Scholar

4 Huang J, Xu Y, Li M, Sun Z, Zhu Z, Song Y, et al. The prognostic impact of occult lymph node metastasis in node-negative gastric cancer: A systemic review and meta-analysis. Ann Surg Oncol 2013; 20: 3927-34.HuangJXuYLiMSunZZhuZSongYThe prognostic impact of occult lymph node metastasis in node-negative gastric cancer: A systemic review and meta-analysisAnn Surg Oncol20132039273410.1245/s10434-013-3021-723892524Search in Google Scholar

5 Cai J, Ikeguchi M, Kaibara N, Sakatani T. Clinicopathological value of immunohistochemical detection of occult involvement in pT3N0 gastric cancer. Gastric Cancer 1999; 2: 95-100.CaiJIkeguchiMKaibaraNSakataniTClinicopathological value of immunohistochemical detection of occult involvement in pT3N0 gastric cancerGastric Cancer199929510010.1007/s10120005003011957080Search in Google Scholar

6 Yanagita S, Natsugoe S, Uenosono Y, Arigami T, Arima H, Kozono T, et al. Detection of micrometastases in sentinel node navigation surgery for gastric cancer. Surg Oncol 2008; 17: 203-10.YanagitaSNatsugoeSUenosonoYArigamiTArimaHKozonoTDetection of micrometastases in sentinel node navigation surgery for gastric cancerSurg Oncol2008172031010.1016/j.suronc.2008.04.00818539025Search in Google Scholar

7 Kubota K, Nakanishi H, Hiki N, Shimizu N, Tsuji E, Yamaguchi H, et al. Quantitative detection of micrometastases in the lymph nodes of gastric cancer patients with Real-time RT-PCR: A comperative study with immunohistochemistry. Int J Cancer 2003; 105: 136-43.KubotaKNakanishiHHikiNShimizuNTsujiEYamaguchiHQuantitative detection of micrometastases in the lymph nodes of gastric cancer patients with Real-time RT-PCR: A comperative study with immunohistochemistryInt J Cancer20031051364310.1002/ijc.1103112672044Search in Google Scholar

8 Osaka H, Yashiro M, Sawada T, Katsuragi K, Hirakawa K. Is a lymph node detected by the dye-guided method a true sentinel node in gastric cancer? Clin Cancer Res 2004; 10: 6912-8.OsakaHYashiroMSawadaTKatsuragiKHirakawaKIs a lymph node detected by the dye-guided method a true sentinel node in gastric cancer?Clin Cancer Res2004106912810.1158/1078-0432.CCR-04-047615501969Search in Google Scholar

9 Shimizu Y, Takeuchi H, Sakakura Y, Saikawa Y, Nakahara T, Mukai M, et al. Molecular detection of sentinel node micrometastases in patients with clinical N0 gastric carcinoma with real-time multiplex reverse transcription-polymerase chain reaction assay. Ann Surg Oncol 2012; 19: 469-77.ShimizuYTakeuchiHSakakuraYSaikawaYNakaharaTMukaiMMolecular detection of sentinel node micrometastases in patients with clinical N0 gastric carcinoma with real-time multiplex reverse transcription-polymerase chain reaction assayAnn Surg Oncol2012194697710.1245/s10434-011-2122-422065193Search in Google Scholar

10 Ishigami S, Natsugoe S, Hokita S, Che X, Tokuda K, Nakajo A, et al. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol 2001; 32: 41-4.IshigamiSNatsugoeSHokitaSCheXTokudaKNakajoAClinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancerJ Clin Gastroenterol20013241410.1097/00004836-200101000-0001011154168Search in Google Scholar

11 Dilege E, Mihmanli M, Demir U, Özer K, Bostancu Ö, Kaya C, et al. Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer. Hepatogastroenterology 2010; 57: 674-7.DilegeEMihmanliMDemirUÖzerKBostancuÖKayaCPrognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancerHepatogastroenterology2010576747Search in Google Scholar

12 Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, et al. The prognostic value of preoperative serum level of CEA and CA19-9 in patients with gastric cancer. Am J Gastroent 1996; 91: 49-53.KoderaYYamamuraYToriiAUesakaKHiraiTYasuiKThe prognostic value of preoperative serum level of CEA and CA19-9 in patients with gastric cancerAm J Gastroent1996914953Search in Google Scholar

13 Mihmanli M, Dilege E, Demir U, Coskun H, Eroglu T, Uysalol MD. The use of tumor markers as predictors of prognosis in gastric cancer. Hepatogastroenterology 2004; 51: 1544-7.MihmanliMDilegeEDemirUCoskunHErogluTUysalolMDThe use of tumor markers as predictors of prognosis in gastric cancerHepatogastroenterology20045115447Search in Google Scholar

14 Tsirlis TD, Kostakis A, Papastratis G, Masselou K, Vlachos I, Papachristodoulou A, et al. Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer. J Surg Oncol 2010; 102: 699-703.TsirlisTDKostakisAPapastratisGMasselouKVlachosIPapachristodoulouAPredictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancerJ Surg Oncol201010269970310.1002/jso.21677Search in Google Scholar

15 Mattar R, Alves de Andrade CR, DiFavero GM, Gama-Rodrigues JJ, Laudanna AA. Preoperative serum levels of CA 72-5, CEA, CA 19-9 and Alpha-fetoprotein in patents with gastric cancer. Rev Hosp Clin Fac Med S Paulo 2002; 57: 89-92.MattarRAlves de AndradeCRDiFaveroGMGama-RodriguesJJLaudannaAAPreoperative serum levels of CA 72-5, CEA, CA 19-9 and Alpha-fetoprotein in patents with gastric cancerRev Hosp Clin Fac Med S Paulo200257899210.1590/S0041-87812002000300001Search in Google Scholar

16 Kannagi R. Carbohydrate antigen Sialyl Lewis a – Its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J 2007; 30: 189-209.KannagiRCarbohydrate antigen Sialyl Lewis a – Its pathophysiological significance and induction mechanism in cancer progressionChang Gung Med J200730189209Search in Google Scholar

17 Duraker N, Celik AN. The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: Comparison with CEA. J Surg Oncol 2001; 76: 266-71.DurakerNCelikANThe prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: Comparison with CEAJ Surg Oncol2001762667110.1002/jso.1044Search in Google Scholar

18 Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011; 14: 113-23.Japanese Gastric Cancer AssociationJapanese gastric cancer treatment guidelines 2010 (ver. 3)Gastric Cancer2011141132310.1007/s10120-011-0042-4Search in Google Scholar

19 Jagric T, Potrc S, Ivanecz A, Horvat M, Plankl M, Mars T. Evaluation of focused sentinel lymph node RT-qPCR screening for micrometastases with the use of the Maruyama computer program. Eur Surg 2013; 45: 270-6.JagricTPotrcSIvaneczAHorvatMPlanklMMarsTEvaluation of focused sentinel lymph node RT-qPCR screening for micrometastases with the use of the Maruyama computer programEur Surg201345270610.1007/s10353-013-0226-8Search in Google Scholar

20 Jagric T, Plakl M, Ivanecz A, Horvat M, Gajzer B, Grubic Z, et al. The prognostic value of micrometastases found intraoperatively in the first drainig lymph node in gastric cancer patients. Zdrav Vestn 2012; 81: 775-83.JagricTPlaklMIvaneczAHorvatMGajzerBGrubicZThe prognostic value of micrometastases found intraoperatively in the first drainig lymph node in gastric cancer patientsZdrav Vestn20128177583Search in Google Scholar

21 Jagric T, Ivanecz A, Horvat M, Plankl M, Kavalar R, Potrc S, et al. Evaluation of a focused sentinel lymph node protocol in node-negative gastric cancer patients, Hepatogastroenterol 2013; 60: 1231-6.JagricTIvaneczAHorvatMPlanklMKavalarRPotrcSEvaluation of a focused sentinel lymph node protocol in node-negative gastric cancer patientsHepatogastroenterol20136012316Search in Google Scholar

22 Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Higashi H, Watanabe T, et al. Clinical impact of micrometastasis of lymph node in gastric cancer. Am Surg 2003; 69: 573-7.IshigamiSNatsugoeSTokudaKNakajoAHigashiHWatanabeTClinical impact of micrometastasis of lymph node in gastric cancerAm Surg2003695737Search in Google Scholar

23 Nakajo A, Natsugoe S, Ishigami S, Matsumoto M, Nakashima S, Hokita S, et al. Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer. Ann Surg Oncol 2000; 8: 158-62.NakajoANatsugoeSIshigamiSMatsumotoMNakashimaSHokitaSDetection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancerAnn Surg Oncol200081586210.1007/s10434-001-0158-6Search in Google Scholar

24 Sievert JR, Kestlmaier R, Busch R, Böttcher K, Roder JD, Müller J, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Brit J Surg 1996; 83: 1144-7.SievertJRKestlmaierRBuschRBöttcherKRoderJDMüllerJBenefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastasesBrit J Surg19968311447Search in Google Scholar

25 Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, Ohro S, et al. Recurrence in early gastric cancer – Presence of micrometastases in lymph node negative early gastric cancer patient with recurrence. Hepatogastroenterol 2007; 54: 620-4.SaitoHOsakiTMurakamiDSakamotoTKanajiSOhroSRecurrence in early gastric cancer – Presence of micrometastases in lymph node negative early gastric cancer patient with recurrenceHepatogastroenterol2007546204Search in Google Scholar

26 Otsuji E, Toma A, Kobayashi S, Okamoto K, Hagiwara A, Yamagishi H. Outcome of profilactic Radical lymphadenectomy with gastrectomy in patients with early gastric carcinoma without lymph node metastases. Cancer 2000; 89: 1425-30.OtsujiETomaAKobayashiSOkamotoKHagiwaraAYamagishiHOutcome of profilactic Radical lymphadenectomy with gastrectomy in patients with early gastric carcinoma without lymph node metastasesCancer20008914253010.1002/1097-0142(20001001)89:7<1425::AID-CNCR3>3.0.CO;2-7Search in Google Scholar

27 Nakajo A, Natsugoe S, Ishigami S, Matsumoto M, Nakashima S, Hokita S, et al. Detection and prediction of micrometastases in the lymph nodes of patients with pN0 gastric cancer. Ann Surg Oncol 2001; 8: 158-62.NakajoANatsugoeSIshigamiSMatsumotoMNakashimaSHokitaSDetection and prediction of micrometastases in the lymph nodes of patients with pN0 gastric cancerAnn Surg Oncol200181586210.1007/s10434-001-0158-6Search in Google Scholar

28 Fukagawa T, Sasako M, Ito S, Nakanishi H, Iinuma H, Natsugoe S. The prognostic signifficance of isolated tumor cells in the lymph nodes of gastric cancer patients. Gastric Cancer 2010; 13: 191-6.FukagawaTSasakoMItoSNakanishiHIinumaHNatsugoeSThe prognostic signifficance of isolated tumor cells in the lymph nodes of gastric cancer patientsGastric Cancer201013191610.1007/s10120-010-0556-1Search in Google Scholar

29 Fukagawa T, Sasako M, Mann GB, Sano T, Katai H, Maruyama K, et al. Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma. Cancer 2001; 92: 753–60.FukagawaTSasakoMMannGBSanoTKataiHMaruyamaKImmunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinomaCancer2001927536010.1002/1097-0142(20010815)92:4<753::AID-CNCR1379>3.0.CO;2-5Search in Google Scholar

30 Cao L, Hu X, Zhang Y, Huang G. Adverse prognosis of clustered-cell versus single-cell micrometastases in pN0 early gastric cancer. J Surg Oncol 2011; 103: 53-6.CaoLHuXZhangYHuangGAdverse prognosis of clustered-cell versus single-cell micrometastases in pN0 early gastric cancerJ Surg Oncol201110353610.1002/jso.21755Search in Google Scholar

31 Kim JJ, Song KY, Hur H, Hur JI, Park SM, Park CH. Lymph node micrometastasis in node negative early gastric cancer. Eur J Surg Oncol 2009; 35: 409-14.KimJJSongKYHurHHurJIParkSMParkCHLymph node micrometastasis in node negative early gastric cancerEur J Surg Oncol2009354091410.1016/j.ejso.2008.05.004Search in Google Scholar

32 Chou HH, Kuo CJ, Hsu JT, Chen TH, Lin CJ, Tseng JH, et al. Clinicopatologic study of node-negative advanced gastric cancer and analysis of factors predicting its recurrence and prognosis. Am J Surgery 2013; 101:623-30.ChouHHKuoCJHsuJTChenTHLinCJTsengJHClinicopatologic study of node-negative advanced gastric cancer and analysis of factors predicting its recurrence and prognosisAm J Surgery20131016233010.1016/j.amjsurg.2012.04.014Search in Google Scholar

33 Iwasaki Y, Sasako M, Yamamoto S, Nakamura K, Sano T, Katai H, et al. Phase II study of preoperative chemotherapy with S-1 and Cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol 2013; 107: 741-5.IwasakiYSasakoMYamamotoSNakamuraKSanoTKataiHPhase II study of preoperative chemotherapy with S-1 and Cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210)J Surg Oncol2013107741510.1002/jso.23301Search in Google Scholar

34 Kodera Y, Nakanishi H, Ito S, Mochizuki Y, Yamamura Y, Fujiwara M, et al. Detection of disseminated cancer cells in linitis plastic-type gastric carcinoma. Jpn J Clin Oncol 2004; 34: 525-31.KoderaYNakanishiHItoSMochizukiYYamamuraYFujiwaraMDetection of disseminated cancer cells in linitis plastic-type gastric carcinomaJpn J Clin Oncol2004345253110.1093/jjco/hyh097Search in Google Scholar

35 Endo K, Sakurai M, Kusumoto E, Uehara H, Yamaguchi S, Tsutsumi N, et al. Biological significance of localized type IV scirrhous gastric carcinoma. Oncol Letters 2012; 3: 94-9.EndoKSakuraiMKusumotoEUeharaHYamaguchiSTsutsumiNBiological significance of localized type IV scirrhous gastric carcinomaOncol Letters2012394910.3892/ol.2011.454Search in Google Scholar

36 Miwa K, Miyazaki I, Sahara H, Fujimura T, Yonemura Y, Noguchi M, et al. Rationale for extensive lymphadenectomy in early gastric carcinoma. Brit J Cancer 1995; 72: 1518-24.MiwaKMiyazakiISaharaHFujimuraTYonemuraYNoguchiMRationale for extensive lymphadenectomy in early gastric carcinomaBrit J Cancer19957215182410.1038/bjc.1995.540Search in Google Scholar

37 Maehara Z, Oshiro T, Endo K, Baba H, Oda S, Ichiyoshi Y, et al. Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996, 119: 397-402.MaeharaZOshiroTEndoKBabaHOdaSIchiyoshiYClinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrenceSurgery199611939740210.1016/S0039-6060(96)80138-3Search in Google Scholar